Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,418 public trials 1,316 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

NCT02116179

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: University of Delaware Center for Drug and Alcohol Studies Coral Gables, Florida, United States

View Trial Details

Completed

Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease

NCT01963845

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: University of California, San Diego San Diego, California, United States

View Trial Details

Completed

Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation

NCT02125071

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +17 more
Locations: The Catholic University, Seoul St Mary Hospital Seoul, South Korea

View Trial Details

Completed

Serine Supplementation for Obese Subjects With Fatty Liver Disease

NCT02599038

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Hanns-Ulrich Marschall Gothenburg, Sweden

Sahlgrenska Academy Gothenburg, Sweden

View Trial Details

Completed

Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)

NCT00586313

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations: University Hospital Indianapolis, Indiana, United States

View Trial Details

Completed

Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection

NCT02483156

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Egyptian Liver Hospital Sherbin, Dakahlia Governorate, Egypt

View Trial Details

Completed

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

NCT00812175

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Many Locations, Alabama, United States

Many Locations, Arizona, United States

Many Locations, Arkansas, United States

Many Locations, California, United States

View all 75 locations

View Trial Details

Completed

An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection

NCT02278419

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Cairo, Egypt

Menoufiya, Egypt

View Trial Details

Completed

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00356564

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany

GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany

View all 42 locations

View Trial Details

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions